Clinical trial
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split…
NCT00424086 · Alachua Government Services, Inc., Industry · Completed
Key facts
| NCT number | NCT00424086 |
|---|---|
| Title | Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) |
| Official title | Single Blind, Randomized, Actively Controlled Phase 1/2 Study to Compare the Safety and Immunogenicity of a Split Virus, Vero Cell Derived, Seasonal Influenza Vaccine (VCIC) With a Licensed, Egg Derived, Split Virus, Seasonal Influenza Vaccine (EIV) |
| Lead sponsor | Alachua Government Services, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Inactivated seasonal influenza vaccine (split virus, vero cell derived), egg derived) [licensed control vaccine] |
| Enrollment | 1,000 |
| Start date | Jan 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Oct 9, 2015 |
| Countries | Austria, Germany, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: